CBNK vs. AMRX
CBNK (Capital Bancorp, Inc.) and AMRX (Amneal Pharmaceuticals, Inc.) are both stocks. CBNK operates in Banks - Regional (Financial Services), while AMRX operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 5 years, CBNK returned 11.85%/yr vs 30.02%/yr for AMRX. Their 0.23 correlation means their historical movements had little consistent relationship.
Performance
CBNK vs. AMRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CBNK achieves a 33.51% return, which is significantly lower than AMRX's 45.40% return.
CBNK
- 1D
- 0.81%
- 1M
- 5.10%
- 6M
- 22.43%
- YTD
- 33.51%
- 1Y
- 22.67%
- 3Y*
- 24.99%
- 5Y*
- 11.85%
- 10Y*
- —
- ALL TIME*
- 15.36%
AMRX
- 1D
- -0.97%
- 1M
- 6.82%
- 6M
- 33.92%
- YTD
- 45.40%
- 1Y
- 133.97%
- 3Y*
- 79.45%
- 5Y*
- 30.02%
- 10Y*
- -5.11%
- ALL TIME*
- 11.78%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $32.37M | $32.67M | $30.54M | |
| $2.14M | $2.02M | $2.23M |
CBNK vs. AMRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
CBNK Capital Bancorp, Inc. | 33.51% | 0.27% | 19.66% | 4.31% | -9.31% | 88.84% | -6.45% | 30.50% | -12.23% |
AMRX Amneal Pharmaceuticals, Inc. | 45.40% | 59.09% | 30.48% | 205.03% | -58.46% | 4.81% | -5.19% | -64.38% | -40.32% |
Correlation
The correlation between CBNK and AMRX is 0.34, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.34 |
Correlation (3Y) Balances recent behavior with more history. | 0.32 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.26 |
Correlation (All Time) Calculated using the full available price history since Sep 26, 2018 | 0.23 |
The correlation between CBNK and AMRX shifts across timeframes, from 0.23 (all time) to 0.34 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
CBNK:
$608.03M
AMRX:
$5.85B
CBNK:
$3.41
AMRX:
$0.48
CBNK:
10.95
AMRX:
37.97
CBNK:
1.28
AMRX:
1.32
CBNK:
2.52
AMRX:
1.92
CBNK:
1.45
AMRX:
182.01
CBNK:
$244.87M
AMRX:
$3.12B
CBNK:
$164.14M
AMRX:
$1.23B
CBNK:
$44.94M
AMRX:
$447.79M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CBNK vs. AMRX — Risk / Return Rank
CBNK
AMRX
CBNK vs. AMRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Capital Bancorp, Inc. (CBNK) and Amneal Pharmaceuticals, Inc. (AMRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CBNK | AMRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.24 | ||
| Sortino ratioReturn per unit of downside risk | -3.37 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.58 | -0.42 |
| Calmar ratioReturn relative to maximum drawdown | 0.88 | 6.07 | -5.19 |
| Martin ratioReturn relative to average drawdown | 1.70 | 15.13 | -13.42 |
Loading charts...
Drawdowns
CBNK vs. AMRX - Drawdown Comparison
The maximum CBNK drawdown since its inception was -53.68%, smaller than the maximum AMRX drawdown of -97.52%. Use the drawdown chart below to compare losses from any high point for CBNK and AMRX.
Loading charts...
Drawdown Indicators
| CBNK | AMRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -53.68% | -97.52% | +43.84% |
Max Drawdown (1Y)Largest decline over 1 year | -23.25% | -22.25% | -1.00% |
Max Drawdown (3Y)Largest decline over 3 years | -24.81% | -26.80% | +1.99% |
Max Drawdown (5Y)Largest decline over 5 years | -43.34% | -78.29% | +34.95% |
Max Drawdown (10Y)Largest decline over 10 years | — | -95.87% | — |
Current DrawdownCurrent decline from peak | -1.32% | -64.30% | +62.98% |
Average DrawdownAverage peak-to-trough decline | -14.90% | -54.42% | +39.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.02% | 8.91% | +3.11% |
Volatility
CBNK vs. AMRX - Volatility Comparison
The current volatility for Capital Bancorp, Inc. (CBNK) is 7.06%, while Amneal Pharmaceuticals, Inc. (AMRX) has a volatility of 9.86%. This indicates that CBNK experiences smaller price fluctuations and is considered to be less risky than AMRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CBNK | AMRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.06% | 9.86% | -2.80% |
Volatility (6M)Calculated over the trailing 6-month period | 17.46% | 25.71% | -8.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.48% | 33.29% | -8.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.45% | 50.81% | -23.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.44% | 65.25% | -18.81% |
Dividends
CBNK vs. AMRX - Dividend Comparison
CBNK's dividend yield for the trailing twelve months is around 1.29%, while AMRX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
AMRX Amneal Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CBNK Capital Bancorp, Inc. | 1.29% | 1.56% | 1.26% | 1.16% | 0.93% | 0.38% |
Financials
CBNK vs. AMRX - Financials Comparison
This section allows you to compare key financial metrics between Capital Bancorp, Inc. and Amneal Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CBNK vs. AMRX - Profitability Comparison
CBNK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Capital Bancorp, Inc. reported a gross profit of 0.00 and revenue of 22.10M. Therefore, the gross margin over that period was 0.0%.
AMRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Amneal Pharmaceuticals, Inc. reported a gross profit of 334.51M and revenue of 796.20M. Therefore, the gross margin over that period was 42.0%.
CBNK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Capital Bancorp, Inc. reported an operating income of 0.00 and revenue of 22.10M, resulting in an operating margin of 0.0%.
AMRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Amneal Pharmaceuticals, Inc. reported an operating income of -1.30M and revenue of 796.20M, resulting in an operating margin of -0.2%.
CBNK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Capital Bancorp, Inc. reported a net income of 14.25M and revenue of 22.10M, resulting in a net margin of 64.5%.
AMRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Amneal Pharmaceuticals, Inc. reported a net income of 57.66M and revenue of 796.20M, resulting in a net margin of 7.2%.
Frequently Asked Questions
CBNK and AMRX have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AMRX has higher volatility (9.86%) compared to CBNK (7.06%). In terms of maximum drawdown, CBNK dropped -53.68% vs AMRX's -97.52%.
AMRX currently has the higher Sharpe Ratio (4.08 vs 0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CBNK and AMRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer